Researchers publish the first comprehensive, 3D analysis of the complete rhabdomyosarcoma genome
In a paper published in NAR Cancer, researchers from the Center for Childhood Cancer Research at Nationwide Childrens and their collaborators report a comprehensive 3D chromatin structural analysis and characterization of rhabdomyosarcoma (RMS). RMS is a pediatric soft-tissue tumor that predominantly affects children between 0 and 4 years, but it can also affect adolescents. Survival rates vary dramatically from 10% to 90% depending on the stage and subtype.
Meng Wang Benjamin Stanton Stanton Lab Childhood Cancer Research At Nationwide Children Childhood Cancer Research Nationwide Children
Source: medicalxpress.com